All articles tagged with #multi cancer early detection
The NHS-Galleri trial, involving 142,250 participants, found that a multi-cancer early detection blood test did not significantly reduce late-stage cancer diagnoses overall, though it detected about 30% of cancers and had a high specificity.
A first-person look at Grail’s Galleri multi-cancer early detection blood test: the $824 home draw returned no cancer signal, but real-world results are mixed and medical groups remain cautious, with limited evidence of mortality benefit and concerns about false positives and missed cancers. While some see potential, experts emphasize that MRI scans or traditional symptom-driven screening remain more established, and readers are advised to discuss symptoms with a doctor and not rely on MCED tests as a sole screening tool.